CompaniesAceragen

Aceragen

defunct

About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

By Phase

PHASE2: 1

By Status

WITHDRAWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

Today

Hover over trial bars to see details

Recent Trials

NCT05641298Lead Sponsor

Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations

PHASE2Withdrawn

Started: Feb 10, 2023 · Completed: Sep 30, 2023

Funding History (20)

8-K

Aug 16, 2023

DEF 14A

Jul 21, 2023

8-K

Jul 21, 2023

DEFA14A

Jul 11, 2023

8-K

Jul 11, 2023

8-K

May 30, 2023

8-K

May 4, 2023

8-K

Mar 30, 2023

8-K

Feb 6, 2023

8-K

Feb 3, 2023